News
Children's Hospital Media and Press Relations
Department of Pediatrics Newsletter
Investigator probes why H1N1 hit young, healthy the hardest
By Carole Bartoo
December 9, 2010


Former patient Jason Martin, who nearly died during last year’s H1N1 flu pandemic, hugs Christina Twone, R.N., during a visit to the Medical Intensive Care Unit. (photo by Daniel Dubois)

Fernando Polak, M.D., is studying why the H1N1 flu virus hit younger, healthy people the hardest. (photo by Susan Urmy)

Last month, Jason Martin returned to the Medical Intensive Care Unit (MICU) at Vanderbilt University Medical Center for the first time since he nearly died there during last year's H1N1 flu pandemic. The tall and burly Warren County, Tenn., ambulance worker - a 30-year-old, father of three young children - broke down and hugged some of the nurses he recognized.

"I got sick on Sept. 12 and didn't come out of it for the next 20 days. I am just so grateful I came through," Martin said, wiping his eyes.

Martin was among the first wave of critically ill Middle Tennesseans, hit hard by the H1N1 flu pandemic in late 2009. A hallmark of pandemic flu throughout history has been its ability to make healthy young and middle-aged adults seriously ill and even kill this population in disproportionate numbers.

In a paper published Dec. 5 in Nature Medicine, Fernando Polack, M.D., the Cesar Milstein Associate Professor of Pediatrics at Vanderbilt, and colleagues in both Argentina and Nashville provide a possible explanation for this phenomenon. The study's findings suggest people are made critically ill, or even killed, by their own immune response.

"Every time there is an influenza pandemic there is a large proportion of younger or middle-aged adults who die," Polack said. "We have always explained these deaths based on presumed virulence of virus, or getting bacterial infection at the same time. We now have vaccines and antibiotics, but still we see middle-aged individuals who die."

Polack directs the INFANT Foundation, a research and clinical institute based in Buenos Aires, in close cooperation with Vanderbilt's Vaccine Center. In Argentina, he had a front row seat for the emergence of the H1N1 flu pandemic, which began there in April 2009.

As the virus burned its way northward through the Southern Hemisphere, Polack and his team went to work looking for evidence of a biomarker he had used before. A biomarker is a protein that can be measured in blood or tissue whose concentration reflects the severity or presence of some disease state.

"We have seen this before. Where non-protective antibody responses are associated with an immune-based disease in the lung," Polack said.

Polack had previously published evidence that an immune response established against a virus can overreact in a violent and uncontrolled fashion when faced with a similar, but not identical, virus.

Patients die or become extremely ill from lung damage inflicted by their own immune system. A molecule called C4d, a product of this biochemical cascade (the complement system), is a marker of the strength of the response.

In adults who died during the 2009 H1N1 pandemic, high levels of C4d in lung tissues suggest a massive, potentially fatal activation of the complement system.

Pulmonary and critical care physician Todd Rice, M.D., assistant professor of Medicine at VUMC, has seen people killed by the "exuberant" and uncontrolled response of the immune system in other diseases - like sepsis.

"This looked every bit like that," Rice recalled about H1N1 patients, including Martin, who arrived in the intensive care unit in mid-September 2009. "It was impressive. These were as sick as any patients I had ever seen. We tried all sorts of things," Rice said.

Ultimately, Vanderbilt's ICU saw 49 adults with H1N1, most age 25 to 45. Martin was one of 40 who survived.

But Polack wanted evidence beyond what he saw in patients in 2009. He asked Joyce Johnson, M.D., professor of Pathology, to look for evidence this phenomenon may have happened during past flu pandemics. Johnson scanned Vanderbilt's hand-penned autopsy ledgers, dating back to 1925.

She was able to locate tissue samples in Vanderbilt's tissue archive and extract half a dozen slices of lung tissue from Nashville patients who died during the 1957 Hong Kong flu pandemic.

Pediatric infectious diseases expert John Williams, M.D., assistant professor of Pediatrics, Microbiology & Immunology, and his lab found the signature for an influenza infection in 4 of the 53-year-old samples, and were able to confirm the lung tissues had high levels of C4d. These patients too had died from an over-reactive immune response.

"C4d is part of the inflammatory cascade, and while it's really good at killing organisms and protecting us, it's sort of the slash and burn approach, capable of causing lots of tissue damage," Johnson said.

But why did infants and the frail elderly escape this mechanism of death in the H1N1 pandemic?

"We found in 2009 the elderly had good immunity because they had seen a very similar virus sometime before 1957. Babies hadn't seen many viruses at all so there was no trigger. It came down to the young adults - primed with an ineffective response. Their bodies already had defenses against previous influenza viruses that look like this one but weren't close enough," Polack said.

While the patient sample in the current study is relatively small: 75 patients, including 23 who died in 2009, and four from 1957, investigators were able to show that other theories, like dampening of interferon, or the triggering of an inflammatory response called a "cytokine storm," were not supported by the evidence. Even the number of viruses present in a flu patient did not seem to correlate with the severity of illness.

"It suggests this (immune over-reaction) is what happens with pandemic to make young healthy adults seriously ill. There are other things that contribute to threat, but this is one of the main things for this age group," Polack said.

While many questions remain, one thing is clear: the H1N1 vaccine offers protection. Patients who died were overwhelmingly unvaccinated. Many fell ill before a vaccine was even available.


 
Vanderbilt University School Of Medicine
Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Department of Pediatrics | 2200 Children's Way | Nashville, Tenn. 37232 | 615.936.1000
© 2017 Vanderbilt University School of Medicine
Monroe Carrell Jr. Children's Hospital at Vanderbilt